Labiotech.eu

rheumatoid arthritis anti il 6r ablynx abbvie

News and Trends 9 Aug 2016

Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

Ablynx has disclosed ‘compelling’ results for its Phase IIb trial in rheumatoid arthritis. But it might have a hard time compelling AbbVie to pay €68M to continue the candidate’s development, as the grass is not as green as it seems… Ablynx‘s impressive list of big Pharma collaborations could soon need an update, as its $840 partnership with […]

August 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 Aug 2016

Yes, Biotech can help you win the Olympic Games of Rio

The world’s eyes are set on the 2016 edition of the Summer Olympics, which started in Rio de Janeiro last week. I had a look at how Biotech has been involved in the Olympics – and how it could define it in the future. The Summer Olympics of 2016 have been marked by its fair […]

August 9, 2016 - 5 minutesmins - By Denise Neves Gameiro

sleep homeostasis sandman channel oxford cncb

News and Trends 8 Aug 2016

The Brain’s Sleep Switch was just discovered, zZz …

Researchers from the University of Oxford have discovered how certain neurons control when we go to sleep. The biology behind it involves an ion channel that reacts to the ‘happy chemical’ dopamine, changing places in the neurons. Sleep is essential to health, with the Center for Disease Control even calling insufficient sleep a public health […]

August 8, 2016 - 3 minutesmins - By Denise Neves Gameiro

endometriosis treatment womens health biotech

News and Trends 8 Aug 2016

A €580M Collaboration for Endometriosis Therapies breaks into Clinical Development

Update (24/07/2017): Bayer and Evotec have announced a second compound from their partnership made it to clinical trials in humans. Consequently, they have decided to extend the partnership for an extra year and develop 4 candidates instead of the original 3. Originally published on 08/08/2016 An endometriosis therapy is now moving to clinical development. It’s […]

August 8, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 5 Aug 2016

Dutch FF Pharma has a Promising Immunotherapy to fight Crohn’s Disease

Arrivederci Italia! We’re going to fly up to the Netherlands for another Biotech-related adventure! This time, we’re visiting Utrecht, the fourth most populated city in the country and home-base to FF Pharma, our Biotech of the Week! City: Utrecht (The Netherlands) Founded: 2012 Employees: N/A Financial Data: €4M Total Raised (as of 12/2015) CEO: Mark De Boer Mission: FF […]

August 5, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 4 Aug 2016

Roche drops Partnership for Hepatitis Immunotherapy

While everybody wants to get the next immunotherapy on the market, Roche is turning its back on one. It’s leaving the partnership with Inovio, which focuses on developing a DNA-based immunotherapy to treat Hepatitis B. Previously, Roche has left projects to focus on immunotherapies, particularly in the hype field of immuno-oncology. This was an important […]

August 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 4 Aug 2016

Marine Drug goes to Phase III trials to treat Lung Cancer

PharmaMar is starting a new Phase III trial, with patients suffering from small cell lung cancer (SCLC). It’ll test the efficacy of its third candidate obtained from marine organisms (PM1183) as a SCLC treatment. PharmaMar is one of the hot Biotechs in Spain, which just saw its second drug finish Phase III trials with good results (and is […]

August 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

cambridge famin C13orf31 macrophage metabolism

News and Trends 3 Aug 2016

Mysterious Immunology Mechanism Unlocked thanks to CRISPR

While studying a mutation connected to inflammatory disease, researchers from the University of Cambridge have found a previously unknown mechanism in immune response. As the cost of NGS plummets, genetic data is growing massively. With the help of bioinformatics, information about genetic variants and mutations can be linked to diseases. Sophia Genetics (Switzerland), Diploid (Belgium) […]

August 3, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 Aug 2016

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position even further by presenting good results from a Phase III of its stem cell therapy (Cx601) treating Crohn’s disease. UPDATE (article originally published on 24/8/2015): TiGenix’s Phase III results were now published in The Lancet. Julián Panés, the global coordinator […]

August 3, 2016 - 3 minutesmins - By Philip Hemme

galvani bioelectronics electroceuticals gsk verily google

News and Trends 2 Aug 2016

Google and GSK invest €630M to create a new Bioelectronics Champion

GSK and Verily Life Sciences are creating a new company together, Galvani Bioelectronics. Along with €630M in investment, it’ll inherit intellectual property to pioneer a new class of therapies – bioelectronic medicines. GSK is one of the big Pharma based in Europe and has had a strong presence in many hype fields of medical Biotech. Examples are […]

August 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

microbiome therapies seres therapeutics ser 009

News and Trends 2 Aug 2016

Microbiome Therapies suffer setback with a Phase II Failure

The hype field of the Microbiome could be taking a step back, as the most advanced program has failed to meet its primary endpoint in a Phase II trial. What does this mean for the emerging class of therapies? As we have seen at Refresh’s Microbiome fireside chat, the field took really big steps in its recent […]

August 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

Best in Biotech 2 Aug 2016

7 Books to turn you into a Biotech Genius over the Summer

As summer is approaching its peak, we thought that you would like to discover some of the Biotech books we love the most. This list (without any particular order) will give you a broad choice of topics, from entrepreneurial journeys to scientific breakthroughs. Enjoy reading and be inspired by these amazing stories! The Antidote: Inside the […]

August 2, 2016 - 4 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

Yes, Biotech can help you win the Olympic Games of Rio

The Brain’s Sleep Switch was just discovered, zZz …

A €580M Collaboration for Endometriosis Therapies breaks into Clinical Development

Dutch FF Pharma has a Promising Immunotherapy to fight Crohn’s Disease

Roche drops Partnership for Hepatitis Immunotherapy

Marine Drug goes to Phase III trials to treat Lung Cancer

Mysterious Immunology Mechanism Unlocked thanks to CRISPR

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Google and GSK invest €630M to create a new Bioelectronics Champion

Microbiome Therapies suffer setback with a Phase II Failure

7 Books to turn you into a Biotech Genius over the Summer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!